Disclosure of Naloxone Medication Data for Public Health Surveillance, Research, Analysis, Education, and Public Reporting. The Program shall disclose naloxone medication data for research, analysis, education, and public reporting: Upon approval by the Department of a written proposal or abstract explaining the purpose and scope of the research, analysis, education, and public reporting; and After redaction of all information that could identify a patient, prescriber, dispenser, or any other individual. The Secretary may waive the requirement of §A(1) of this regulation for requests from units of the Department. The Program may disclose de-identified naloxone medication data for public health surveillance purposes. The Program may not disclose identifiable naloxone medication data to any entity, including but not limited to prescribers or dispensers.